Role of interaction between reactive oxygen species and ferroptosis pathway in methylglyoxal-induced injury in mouse embryonic osteoblasts.
10.12122/j.issn.1673-4254.2022.01.13
- Author:
Yuan Yi FENG
1
;
Dong Mei YANG
1
;
Xi Mei ZHI
2
;
Hai Ou DENG
2
;
Wei Jie ZHANG
2
;
Rui Xue WANG
2
;
Wen WU
2
Author Information
1. Second School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China.
2. Department of Endocrinology, East Ward of Guangdong Geriatric Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
- Publication Type:Journal Article
- Keywords:
diabetic osteoporosis;
ferroptosis;
methylglyoxal;
osteoblasts;
reactive oxygen species
- MeSH:
Animals;
Cell Survival;
Ferroptosis;
Mice;
Osteoblasts;
Pyruvaldehyde/metabolism*;
Reactive Oxygen Species/metabolism*
- From:
Journal of Southern Medical University
2022;42(1):108-115
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the interaction between reactive oxygen species (ROS) and ferroptosis in methylglyoxalinduced injury of mouse embryonic osteoblasts (MC3T3-E1 cells).
METHODS:MC3T3-E1 cells were treated with methylglyoxal to establish a cell model of diabetic osteoporosis. CCK-8 assay was used to detect the viability of MC3T3-E1 cells. Rhodamine 123 staining followed by photofluorography was used to examine mitochondrial membrane potential (MMP). The intracellular ROS level was detected by 2', 7'-dichlorodihydrofluorescein diacetate staining with photofluorograph. Alkaline phosphatase (ALP) activity in the cells was detected using an ALP kit, the number of mineralized nodules was determined with alizarin red S staining, and the level of iron ions was detected using a detection kit. The expression level of glutathione peroxidase 4 (GPX4, a marker protein that inhibits ferroptosis) in the osteoblasts was determined using Western blotting.
RESULTS:Treatment of MC3T3-E1 cells with 0.6 mmol/L methylglyoxal for 24 h significantly inhibited the expression level of GPX4 (P < 0.001), increased intracellular iron ion concentration, decreased the cell viability, increased the loss of MMP and intracellular ROS level, decreased both ALP activity and the number of mineralized nodules in the cells (P < 0.001). Co-treatment of MC3T3-E1 cells with 2 mmol/L N-acetylcysteine (NAC, a ROS scavenger) and methylglyoxal significantly increased the expression level of GPX4 (P < 0.01); co-treatment with 4 mmo/L FER-1 (a ferroptosis inhibitor) and methylglyoxal obviously decreased the intracellular ROS level (P < 0.001). Co-treatment of the cells either with NAC and methylglyoxal or with FER-1 and methylglyoxal attenuated methylglyoxal-induced injuries in the osteoblasts (P < 0.001).
CONCLUSION:The interaction between ROS and ferroptosis pathway plays an important role in methylglyoxal-induced injury of mouse embryonic osteoblasts.
